Radiation proctitis in the rat. Sequential changes and effects of anti-inflammatory agents

Area of Science:

• Radiation oncology
• Gastroenterology
• Animal models in research

Background:

• Radiation proctitis is a common complication of pelvic radiotherapy.
• Developing reliable animal models is crucial for understanding and treating radiation-induced gastrointestinal damage.

Purpose of the Study:

• To establish and validate a female Wistar rat model for radiation proctitis.
• To investigate the dose-response relationship and temporal changes in radiation proctitis.
• To evaluate the efficacy of potential therapeutic agents in this model.

Main Methods:

• Female Wistar rats received single-dose irradiation to the distal colon.
• Animals were assessed via clinical examination, colonoscopy, and histological evaluation.
• Dose-ranging studies (10-30 Gy) and daily monitoring of 20 Gy treated rats were performed.
• The effects of aspirin, indomethacin, piroxicam, misoprostol, and sucralfate were assessed.

Main Results:

• Irradiation induced dose-dependent clinical and histological changes, peaking 7-15 days post-exposure.
• Colonoscopic findings included mucosal edema, erosion, and ulceration.
• Histological analysis revealed crypt abscess and mural wall necrosis, mirroring human radiation proctitis.
• Tested pharmacological agents did not alter the course of radiation proctitis.

Conclusions:

• The female Wistar rat model accurately replicates human radiation proctitis.
• This model allows for detailed study of endoscopic, histological, and clinical changes.
• The model is suitable for evaluating therapeutic interventions for radiation proctitis.